HEADER HYDROLASE 14-MAR-00 1ELV TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S TITLE 2 PROTEASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: COMPLEMENT C1S COMPONENT; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CCP2-SP CATALYTIC FRAGMENT: ASP363-ASP-673 SEGMENT PRECEDED COMPND 5 BY AN ASP-LEU SEQUENCE ADDED AT THE N-TERMINAL END; COMPND 6 EC: 3.4.21.42; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VIRUS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PNT-BAC/CCP2-AP-SP; SOURCE 12 OTHER_DETAILS: BAC-TO-BAC EXPRESSION SYSTEM KEYWDS TRYPSIN-LIKE SERIN PROTEASE, CCP (OR SUSHI OR SCR)MODULE, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR C.GABORIAUD,V.ROSSI,I.BALLY,G.ARLAUD,J.-C.FONTECILLA-CAMPS REVDAT 8 03-NOV-21 1ELV 1 REMARK SEQADV HETSYN REVDAT 7 29-JUL-20 1ELV 1 COMPND REMARK HETNAM LINK REVDAT 7 2 1 SITE ATOM REVDAT 6 14-FEB-18 1ELV 1 REMARK REVDAT 5 04-OCT-17 1ELV 1 REMARK REVDAT 4 13-JUL-11 1ELV 1 VERSN REVDAT 3 24-FEB-09 1ELV 1 VERSN REVDAT 2 01-APR-03 1ELV 1 JRNL REVDAT 1 14-MAR-01 1ELV 0 JRNL AUTH C.GABORIAUD,V.ROSSI,I.BALLY,G.J.ARLAUD,J.C.FONTECILLA-CAMPS JRNL TITL CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN JRNL TITL 2 COMPLEMENT C1S: A SERINE PROTEASE WITH A HANDLE. JRNL REF EMBO J. V. 19 1755 2000 JRNL REFN ISSN 0261-4189 JRNL PMID 10775260 JRNL DOI 10.1093/EMBOJ/19.8.1755 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 15.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 38816 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.186 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1969 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2333 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 62 REMARK 3 SOLVENT ATOMS : 317 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.70 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.020 ; NULL REMARK 3 ANGLE DISTANCE (A) : 0.024 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: LIKELY BECAUSE OF RADIATION DAMAGES, REMARK 3 THE INTERCHAIN DISULFIDE BRIDGE (A410-A534) IS NOT FORMED, REMARK 3 SEVERAL CYSTEINES ARE OBSERVED WITH DUAL CONFORMATION (A371, REMARK 3 A410, A580, A613) AND DENSITY IS LACKING AT THE END OF SEVERAL REMARK 3 GLU (A351, A359, A372, A373, A385, A397, A402, A506), ASP (A357, REMARK 3 A541), LYS (A629) AND MET (A545) RESIDUES. (THIS IS BRIEFLY REMARK 3 DISCUSSED IN THE ABOVE REFERENCE). REMARK 4 REMARK 4 1ELV COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAR-00. REMARK 100 THE DEPOSITION ID IS D_1000010711. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-SEP-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.93 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 115710 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 15.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.0 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03700 REMARK 200 FOR THE DATA SET : 16.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.75 REMARK 200 COMPLETENESS FOR SHELL (%) : 75.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.50 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.24700 REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: WARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4K 34%, AMMONIUM SULFATE 100MM, PH REMARK 280 7.4, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 39.82500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 341 REMARK 465 ASN A 380 REMARK 465 GLY A 381 REMARK 465 GLU A 418 REMARK 465 GLU A 419 REMARK 465 LYS A 420 REMARK 465 GLN A 421 REMARK 465 ARG A 422 REMARK 465 THR A 479 REMARK 465 SER A 480 REMARK 465 ARG A 481 REMARK 465 LEU A 482 REMARK 465 ALA A 483 REMARK 465 LYS A 484 REMARK 465 SER A 485 REMARK 465 LYS A 584 REMARK 465 VAL A 585 REMARK 465 GLU A 586 REMARK 465 LYS A 587 REMARK 465 PRO A 588 REMARK 465 THR A 589 REMARK 465 ALA A 590 REMARK 465 ASP A 591 REMARK 465 ALA A 592 REMARK 465 GLU A 593 REMARK 465 THR A 669 REMARK 465 PRO A 670 REMARK 465 ARG A 671 REMARK 465 GLU A 672 REMARK 465 ASP A 673 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 342 CG CD1 CD2 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 348 CD OE1 OE2 REMARK 480 GLU A 351 CG CD OE1 OE2 REMARK 480 GLU A 359 CG CD REMARK 480 GLU A 372 OE1 OE2 REMARK 480 GLU A 373 CG CD OE1 OE2 REMARK 480 GLU A 385 CG CD OE1 OE2 REMARK 480 GLU A 397 CD OE1 OE2 REMARK 480 GLU A 402 OE1 REMARK 480 LYS A 405 CD CE NZ REMARK 480 GLU A 415 OE1 OE2 REMARK 480 GLU A 467 OE1 REMARK 480 LYS A 486 CD CE REMARK 480 GLU A 506 CG CD OE1 OE2 REMARK 480 LYS A 521 CE NZ REMARK 480 ASP A 541 CG OD1 OD2 REMARK 480 MET A 545 CG SD CE REMARK 480 LYS A 629 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 385 O HOH A 192 1.61 REMARK 500 OE2 GLU A 506 O HOH A 197 1.76 REMARK 500 O6 NAG B 1 O5 FUC B 3 2.10 REMARK 500 O LEU A 577 SG CYS A 580 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 351 CG GLU A 351 CD 0.109 REMARK 500 GLU A 359 CD GLU A 359 OE2 0.112 REMARK 500 GLU A 397 CG GLU A 397 CD 0.101 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLU A 467 OE1 - CD - OE2 ANGL. DEV. = 10.8 DEGREES REMARK 500 LYS A 521 CD - CE - NZ ANGL. DEV. = -14.2 DEGREES REMARK 500 ARG A 566 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 451 -178.57 -177.19 REMARK 500 THR A 646 -104.32 -118.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 GLU A 359 0.07 SIDE CHAIN REMARK 500 GLU A 415 0.14 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: CAT REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: THE CATALYTIC TRIAD IS: HIS A460 (57), ASP A514 REMARK 800 (102), SER A617 (195) (RESIDUE NUMBERS IN THE REFERENCE REMARK 800 CHYMOTRYPSINOGEN MOLECULE). DBREF 1ELV A 343 673 UNP P09871 C1S_HUMAN 358 688 SEQADV 1ELV ASP A 341 UNP P09871 ENGINEERED MUTATION SEQADV 1ELV LEU A 342 UNP P09871 ENGINEERED MUTATION SEQRES 1 A 333 ASP LEU ASP CYS GLY ILE PRO GLU SER ILE GLU ASN GLY SEQRES 2 A 333 LYS VAL GLU ASP PRO GLU SER THR LEU PHE GLY SER VAL SEQRES 3 A 333 ILE ARG TYR THR CYS GLU GLU PRO TYR TYR TYR MET GLU SEQRES 4 A 333 ASN GLY GLY GLY GLY GLU TYR HIS CYS ALA GLY ASN GLY SEQRES 5 A 333 SER TRP VAL ASN GLU VAL LEU GLY PRO GLU LEU PRO LYS SEQRES 6 A 333 CYS VAL PRO VAL CYS GLY VAL PRO ARG GLU PRO PHE GLU SEQRES 7 A 333 GLU LYS GLN ARG ILE ILE GLY GLY SER ASP ALA ASP ILE SEQRES 8 A 333 LYS ASN PHE PRO TRP GLN VAL PHE PHE ASP ASN PRO TRP SEQRES 9 A 333 ALA GLY GLY ALA LEU ILE ASN GLU TYR TRP VAL LEU THR SEQRES 10 A 333 ALA ALA HIS VAL VAL GLU GLY ASN ARG GLU PRO THR MET SEQRES 11 A 333 TYR VAL GLY SER THR SER VAL GLN THR SER ARG LEU ALA SEQRES 12 A 333 LYS SER LYS MET LEU THR PRO GLU HIS VAL PHE ILE HIS SEQRES 13 A 333 PRO GLY TRP LYS LEU LEU ALA VAL PRO GLU GLY ARG THR SEQRES 14 A 333 ASN PHE ASP ASN ASP ILE ALA LEU VAL ARG LEU LYS ASP SEQRES 15 A 333 PRO VAL LYS MET GLY PRO THR VAL SER PRO ILE CYS LEU SEQRES 16 A 333 PRO GLY THR SER SER ASP TYR ASN LEU MET ASP GLY ASP SEQRES 17 A 333 LEU GLY LEU ILE SER GLY TRP GLY ARG THR GLU LYS ARG SEQRES 18 A 333 ASP ARG ALA VAL ARG LEU LYS ALA ALA ARG LEU PRO VAL SEQRES 19 A 333 ALA PRO LEU ARG LYS CYS LYS GLU VAL LYS VAL GLU LYS SEQRES 20 A 333 PRO THR ALA ASP ALA GLU ALA TYR VAL PHE THR PRO ASN SEQRES 21 A 333 MET ILE CYS ALA GLY GLY GLU LYS GLY MET ASP SER CYS SEQRES 22 A 333 LYS GLY ASP SER GLY GLY ALA PHE ALA VAL GLN ASP PRO SEQRES 23 A 333 ASN ASP LYS THR LYS PHE TYR ALA ALA GLY LEU VAL SER SEQRES 24 A 333 TRP GLY PRO GLN CYS GLY THR TYR GLY LEU TYR THR ARG SEQRES 25 A 333 VAL LYS ASN TYR VAL ASP TRP ILE MET LYS THR MET GLN SEQRES 26 A 333 GLU ASN SER THR PRO ARG GLU ASP MODRES 1ELV ASN A 391 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET FUC B 3 10 HET SO4 A2001 5 HET SO4 A2002 5 HET NES A2003 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM FUC ALPHA-L-FUCOPYRANOSE HETNAM SO4 SULFATE ION HETNAM NES 2-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)- HETNAM 2 NES ETHANESULFONIC ACID HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN FUC ALPHA-L-FUCOSE; 6-DEOXY-ALPHA-L-GALACTOPYRANOSE; L- HETSYN 2 FUC FUCOSE; FUCOSE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 2 FUC C6 H12 O5 FORMUL 3 SO4 2(O4 S 2-) FORMUL 5 NES C6 H15 N O6 S FORMUL 6 HOH *317(H2 O) HELIX 1 1 ASP A 430 PHE A 434 5 5 HELIX 2 2 ALA A 458 GLU A 463 1 6 HELIX 3 3 SER A 539 ASN A 543 5 5 HELIX 4 4 PRO A 576 GLU A 582 1 7 HELIX 5 5 TYR A 656 ASN A 667 1 12 SHEET 1 A 4 GLY A 353 VAL A 355 0 SHEET 2 A 4 VAL A 366 CYS A 371 -1 O THR A 370 N LYS A 354 SHEET 3 A 4 GLU A 385 CYS A 388 -1 O TYR A 386 N ILE A 367 SHEET 4 A 4 TRP A 394 VAL A 395 -1 N VAL A 395 O HIS A 387 SHEET 1 B 2 TYR A 376 MET A 378 0 SHEET 2 B 2 CYS A 406 PRO A 408 -1 N VAL A 407 O TYR A 377 SHEET 1 C 7 LEU A 549 GLY A 554 0 SHEET 2 C 7 LYS A 568 ALA A 575 -1 O LYS A 568 N GLY A 554 SHEET 3 C 7 MET A 601 GLY A 605 -1 O CYS A 603 N ALA A 575 SHEET 4 C 7 TYR A 647 ARG A 652 -1 N GLY A 648 O ALA A 604 SHEET 5 C 7 PHE A 632 TRP A 640 -1 O LEU A 637 N THR A 651 SHEET 6 C 7 ALA A 620 GLN A 624 -1 N PHE A 621 O GLY A 636 SHEET 7 C 7 LEU A 549 GLY A 554 -1 O LEU A 551 N ALA A 622 SHEET 1 D 7 MET A 487 LEU A 488 0 SHEET 2 D 7 MET A 470 TYR A 471 -1 O MET A 470 N LEU A 488 SHEET 3 D 7 GLN A 437 PHE A 440 -1 N PHE A 439 O TYR A 471 SHEET 4 D 7 ALA A 445 ASN A 451 -1 O ALA A 445 N PHE A 440 SHEET 5 D 7 TRP A 454 THR A 457 -1 O TRP A 454 N ILE A 450 SHEET 6 D 7 ALA A 516 LEU A 520 -1 O ALA A 516 N THR A 457 SHEET 7 D 7 PRO A 490 ILE A 495 -1 N GLU A 491 O ARG A 519 SSBOND 1 CYS A 344 CYS A 388 1555 1555 2.02 SSBOND 2 CYS A 371 CYS A 406 1555 1555 2.04 SSBOND 3 CYS A 580 CYS A 603 1555 1555 2.03 SSBOND 4 CYS A 613 CYS A 644 1555 1555 2.02 LINK ND2 ASN A 391 C1 NAG B 1 1555 1555 1.39 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.41 LINK O6 NAG B 1 C1 FUC B 3 1555 1555 1.40 CISPEP 1 GLU A 373 PRO A 374 0 1.37 CISPEP 2 ASN A 442 PRO A 443 0 -0.27 SITE 1 CAT 3 HIS A 460 ASP A 514 SER A 617 CRYST1 39.080 79.650 60.210 90.00 91.24 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.025590 0.000000 0.000550 0.00000 SCALE2 0.000000 0.012550 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016610 0.00000